INDIVIOR PLC (INDV) Stock Overview
USA - NASDAQ:INDV - GB00BN4HT335 - Common Stock
INDV Key Statistics, Chart & Performance
The current stock price of INDV is 29.13 USD. In the past month the price increased by 25.24%. In the past year, price increased by 211.55%.
INDV Latest News, Press Relases and Analysis
INDV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 52.29 | 799.29B | ||
| JNJ | JOHNSON & JOHNSON | 18.21 | 455.30B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.55 | 255.30B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.7 | 237.35B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 12.86 | 222.35B | ||
| MRK | MERCK & CO. INC. | 11.21 | 215.51B | ||
| PFE | PFIZER INC | 7.17 | 138.10B | ||
| SNY | SANOFI-ADR | 11.52 | 124.14B | ||
| GSK | GSK PLC-SPON ADR | 7.67 | 94.41B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.78 | 92.86B | ||
| ZTS | ZOETIS INC | 23.17 | 63.86B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 47.25 | 41.78B |
Related stock screener links
About INDV
Company Profile
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. The company is headquartered in Slough, Berkshire and currently employs 1,030 full-time employees. The company went IPO on 2014-12-24. The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The firm sells its products in the United States and in other selected areas of the world.
Company Info
INDIVIOR PLC
234 Bath Road
SLOUGH BERKSHIRE GB
Employees: 1030
Phone: 448043791090
INDIVIOR PLC / INDV FAQ
What does INDV do?
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. The company is headquartered in Slough, Berkshire and currently employs 1,030 full-time employees. The company went IPO on 2014-12-24. The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The firm sells its products in the United States and in other selected areas of the world.
Can you provide the latest stock price for INDIVIOR PLC?
The current stock price of INDV is 29.13 USD. The price increased by 15.41% in the last trading session.
Does INDV stock pay dividends?
INDV does not pay a dividend.
What is the ChartMill technical and fundamental rating of INDV stock?
INDV has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the market expecting INDV stock to perform?
8 analysts have analysed INDV and the average price target is 14.88 USD. This implies a price decrease of -48.92% is expected in the next year compared to the current price of 29.13.
Is INDIVIOR PLC (INDV) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on INDV.
What is the market capitalization of INDV stock?
INDIVIOR PLC (INDV) has a market capitalization of 3.63B USD. This makes INDV a Mid Cap stock.
INDV Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to INDV. When comparing the yearly performance of all stocks, INDV is one of the better performing stocks in the market, outperforming 96.89% of all stocks.
INDV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to INDV. INDV has an average financial health and profitability rating.
INDV Financial Highlights
Over the last trailing twelve months INDV reported a non-GAAP Earnings per Share(EPS) of 1.75. The EPS decreased by -24.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
INDV Forecast & Estimates
8 analysts have analysed INDV and the average price target is 14.88 USD. This implies a price decrease of -48.92% is expected in the next year compared to the current price of 29.13.
For the next year, analysts expect an EPS growth of 8.11% and a revenue growth 3.53% for INDV